Search Results for "Mirrx Therapeutics"
06:33 EDT 23rd May 2013 | BioPortfolio
Original Source: Mirrx Therapeutics
Mirrx Therapeutics is developing a novel microRNA-blocking technology, Blockmirs, which are antisense oligonucleotides that bind to a microRNA binding site on an mRNA. This unique approach blocks single microRNA:mRNA interactions, resulting in extremely targeted regulation of specific mRNAs, thereby potentially reducing unintended effects on gene activity. www.mirrx.com
Matching Channels
None
Matching News
None
Matching PubMed Articles
None
Search Whole site using Google
Loading
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
